Bilateral SLN Mapping for Cervical Cancer with ICG and Robotic Fluorescence Imaging is Associated with Greater Accuracy in Detecting Metastatic Disease
A.M. Tran,W. Yang,J.F. Boggess,L.D. Kowalski,J.M. Scalici,L.A. Cantrell,K.M. Schuler,A. Ivanova,R.K. Hanna,E.C. Rossi
DOI: https://doi.org/10.1016/j.ygyno.2016.04.080
IF: 5.304
2016-01-01
Gynecologic Oncology
Abstract:Objectives: Sentinel lymph node (SLN) mapping with indocyanine green (ICG) and near-infrared fluorescence imaging (NIRFI) has been described for cervical cancers. However, only small published series have evaluated the accuracy of this technique in this disease. The FIRES trial is a multicenter prospective cohort study including women undergoing hysterectomy and lymphadenectomy for endometrial and cervical cancer. Our objective was to evaluate the accuracy of this SLN mapping technique in detecting occult metastatic disease in cervical cancer among patients undergoing a standardized technique by surgeons at multiple centers.Methods: Patients with stage IA2 to 1B1 cervical cancer (all histologies) were enrolled in the study between February 2012 and July 2015. Patients received 1 mg of ICG intracervical injection and underwent SLN mapping using robotic NIRFI as well as completion pelvic lymphadenectomies. Negative SLN specimens underwent ultrastaging with immunohistochemistry to cytokeratin. Detection rate, sensitivity, and false-negative predictive value were calculated. Fisher exact test was used to compare dichotomous variables between node-positive and -negative groups. The study is registered with clinicaltrials.gov.Results: A total of 67 patients were enrolled at 10 centers by 17 surgeons. Of these, 14 patients (21%) had pelvic nodal metastases. In 60 patients, at least 1 SLN was detected (90%). The rate of bilateral mapping was 61%. Of the 11 patients with metastases who underwent mapping, 7 had positive SLNs (sensitivity 64%), with 4 patients having a false-negative SLN (7.5%), and a negative predictive value (NPV) of 92.5%. Of the 4 patients with false-negative SLNs, 3 mapped unilaterally with the positive non-SLN found on the unmapped side. One patient had an empty unilateral SLN specimen on final pathology (false-positive mapping). Patients who had failed bilateral mapping were significantly more likely to have positive lymph nodes (P = .01). Patients with true bilateral mapping had 100% sensitivity and NPV for detecting metastatic disease.Conclusions: Bilateral SLN mapping achieved with ICG and robotic NIRFI is associated with high accuracy in detecting metastatic cervical cancer. In the case of unilateral mapping or failed mapping, a side-specific complete lymphadenectomy should be performed. Objectives: Sentinel lymph node (SLN) mapping with indocyanine green (ICG) and near-infrared fluorescence imaging (NIRFI) has been described for cervical cancers. However, only small published series have evaluated the accuracy of this technique in this disease. The FIRES trial is a multicenter prospective cohort study including women undergoing hysterectomy and lymphadenectomy for endometrial and cervical cancer. Our objective was to evaluate the accuracy of this SLN mapping technique in detecting occult metastatic disease in cervical cancer among patients undergoing a standardized technique by surgeons at multiple centers. Methods: Patients with stage IA2 to 1B1 cervical cancer (all histologies) were enrolled in the study between February 2012 and July 2015. Patients received 1 mg of ICG intracervical injection and underwent SLN mapping using robotic NIRFI as well as completion pelvic lymphadenectomies. Negative SLN specimens underwent ultrastaging with immunohistochemistry to cytokeratin. Detection rate, sensitivity, and false-negative predictive value were calculated. Fisher exact test was used to compare dichotomous variables between node-positive and -negative groups. The study is registered with clinicaltrials.gov. Results: A total of 67 patients were enrolled at 10 centers by 17 surgeons. Of these, 14 patients (21%) had pelvic nodal metastases. In 60 patients, at least 1 SLN was detected (90%). The rate of bilateral mapping was 61%. Of the 11 patients with metastases who underwent mapping, 7 had positive SLNs (sensitivity 64%), with 4 patients having a false-negative SLN (7.5%), and a negative predictive value (NPV) of 92.5%. Of the 4 patients with false-negative SLNs, 3 mapped unilaterally with the positive non-SLN found on the unmapped side. One patient had an empty unilateral SLN specimen on final pathology (false-positive mapping). Patients who had failed bilateral mapping were significantly more likely to have positive lymph nodes (P = .01). Patients with true bilateral mapping had 100% sensitivity and NPV for detecting metastatic disease. Conclusions: Bilateral SLN mapping achieved with ICG and robotic NIRFI is associated with high accuracy in detecting metastatic cervical cancer. In the case of unilateral mapping or failed mapping, a side-specific complete lymphadenectomy should be performed.